Analyst Reco.

23/01 Bernstein Downgrades Confluent to Market Perform From Outperform MT
15/12 Deutsche Bank Downgrades Confluent to Hold From Buy, Lifts Price Target to $31 From $29 MT
10/12 Guggenheim Downgrades Confluent to Neutral From Buy MT
09/12 Oppenheimer Downgrades Confluent to Perform From Outperform MT
09/12 UBS Downgrades Confluent to Neutral From Buy, Lifts Price Target to $31 From $29 MT
09/12 Needham Downgrades Confluent to Hold From Buy MT
09/12 Canaccord Genuity Downgrades Confluent to Hold From Buy, Adjusts PT to $31 From $27 MT
09/12 Deutsche Bank Downgrades Confluent to Hold From Buy, Adjusts PT to $31 From $29 MT
09/12 Mizuho Securities Downgrades Confluent to Neutral From Outperform, Adjusts PT to $31 From $26 MT
09/12 DA Davidson Downgrades Confluent to Neutral From Buy, Adjusts Price Target to $31 From $29 MT
09/12 Raymond James Downgrades Confluent to Market Perform From Outperform MT
09/12 RBC Downgrades Confluent to Sector Perform From Outperform, Lifts Price Target to $31 From $30 MT
08/12 Truist Securities Downgrades Confluent to Hold From Buy, Adjusts PT to $31 From $29 MT
28/25/28 Confluent's 2026 Growth Profile Seen Improving, Morgan Stanley Says MT
28/25/28 UBS Adjusts Confluent Price Target to $29 From $28, Maintains Buy Rating MT
28/25/28 Oppenheimer Adjusts Confluent Price Target to $29 From $26, Maintains Outperform Rating MT
28/25/28 Truist Raises Price Target on Confluent to $29 From $27, Keeps Buy Rating MT
28/25/28 Deutsche Bank Raises Price Target on Confluent to $29 From $25, Keeps Buy Rating MT
28/25/28 RBC Raises Price Target on Confluent to $30 From $27, Keeps Outperform Rating MT
28/25/28 Morgan Stanley Raises Price Target on Confluent to $27 From $25, Keeps Equalweight Rating MT
08/25/08 Confluent Reportedly Explores Sale After Receiving Acquisition Interest CI
04/25/04 Deutsche Bank Adjusts Confluent Price Target to $25 From $28, Maintains Buy Rating MT
31/25/31 UBS Adjusts Price Target on Confluent to $28 From $32, Maintains Buy Rating MT
31/25/31 RBC Cuts Price Target on Confluent to $25 From $28, Keeps Outperform Rating MT
31/25/31 Capital One Downgrades Confluent to Equal Weight From Overweight, Adjusts Price Target to $21 From $27 MT
No results match your criteria